The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Endocrine Dysfunction in Prader-Willi Syndrome: A Review with Special Reference to GH
Abstract
Prader-Willi syndrome is a genetic disorder occurring in 1 in 10,000–16,000 live-born infants. In the general population, approximately 60 people in every 1,000,000 are affected. The condition is characterized by short stature, low lean body mass, muscular hypotonia, mental retardation, behavioral abnormalities, dysmorphic features, and excessive appetite with progressive obesity. Furthermore, morbidity and mortality are high, probably as a result of gross obesity. Most patients have reduced GH secretory capacity and hypogonadotropic hypogonadism, suggesting hypothalamic-pituitary dysfunction. Replacement of GH and/or sex hormones may therefore be beneficial in Prader-Willi syndrome, and several clinical trials have now evaluated GH replacement therapy in affected children. Results of GH treatment have been encouraging: improved growth, increased lean body mass, and reduced fat mass. There was also some evidence of improvements in respiratory function and physical activity. The long-term benefits of GH treatment are, however, still to be established. Similarly, the role of sex hormone replacement therapy needs to be clarified as few data exist on its efficacy and potential benefits. In summary, Prader-Willi syndrome is a disabling condition associated with GH deficiency and hypogonadism. More active treatment of these endocrine disorders is likely to benefit affected individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prader-Willi Syndrome: Consensus Diagnostic Criteria
Holm, V. A., Cassidy, S. B., Butler, M. G., Hanchett, J. M., Greenswag, L. R., Whitman, B. Y., & Greenberg, F. (1993) · Pediatrics · doi:10.1542/peds.91.2.398 · Cited by 1,278
Karason, K., Lindroos, A. K., Stenlöf, K., & Sjöström, L. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.12.1797 · Cited by 168
Cited by
Cassidy, S. B., Schwartz, S., Miller, J. L., & Driscoll, D. J. (2012) · Genetics in Medicine · doi:10.1038/gim.0b013e31822bead0 · Cited by 1,452
Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
van der Lely, A. J., Tschöp, M., Heiman, M. L., & Ghigo, E. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0029 · Cited by 1,187
Elevated plasma ghrelin levels in Prader–Willi syndrome
Cummings, D. E., Clement, K., Purnell, J. Q., Vaisse, C., Foster, K. E., Frayo, R. S., Schwartz, M. W., Basdevant, A., & Weigle, D. S. (2002) · Nature Medicine · doi:10.1038/nm0702-643 · Cited by 600
Nutritional phases in Prader–Willi syndrome
Miller, J. L., Lynn, C. H., Driscoll, D. C., Goldstone, A. P., Gold, J., Kimonis, V., Dykens, E., Butler, M. G., Shuster, J. J., & Driscoll, D. J. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33951 · Cited by 447
Prader-Willi syndrome: advances in genetics, pathophysiology and treatment
Goldstone, A. P. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2003.11.003 · Cited by 393
Metadata
- Authors
- Burman, P., Ritzén, E. M., & Lindgren, A. C.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2001-12-01
- Volume
- 22
- Issue
- 6
- Pages
- 787-799
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1977047462
- Cited by
- 404
- References
- 2
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endocrine Dysfunction in Prader-Willi Syndrome: A Review with Special Reference to GH. https://app.cochat.ai/papers/10.1210/edrv.22.6.0447
- The paper
- Burman, P., Ritzén, E. M., & Lindgren, A. C. (2001). Endocrine Dysfunction in Prader-Willi Syndrome: A Review with Special Reference to GH. Endocrine Reviews. https://doi.org/10.1210/edrv.22.6.0447
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.